1
|
Wuttisarnwattana P, Eck BL, Gargesha M, Wilson DL. Optimal slice thickness for improved accuracy of quantitative analysis of fluorescent cell and microsphere distribution in cryo-images. Sci Rep 2023; 13:10907. [PMID: 37407807 DOI: 10.1038/s41598-023-37927-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/09/2022] [Accepted: 06/29/2023] [Indexed: 07/07/2023] Open
Abstract
Cryo-imaging has been effectively used to study the biodistribution of fluorescent cells or microspheres in animal models. Sequential slice-by-slice fluorescent imaging enables detection of fluorescent cells or microspheres for corresponding quantification of their distribution in tissue. However, if slices are too thin, there will be data overload and excessive scan times. If slices are too thick, then cells can be missed. In this study, we developed a model for detection of fluorescent cells or microspheres to aid optimal slice thickness determination. Key factors include: section thickness (X), fluorescent cell intensity (Ifluo), effective tissue attenuation coefficient (μT), and a detection threshold (T). The model suggests an optimal slice thickness value that provides near-ideal sensitivity while minimizing scan time. The model also suggests a correction method to compensate for missed cells in the case that image data were acquired with overly large slice thickness. This approach allows cryo-imaging operators to use larger slice thickness to expedite the scan time without significant loss of cell count. We validated the model using real data from two independent studies: fluorescent microspheres in a pig heart and fluorescently labeled stem cells in a mouse model. Results show that slice thickness and detection sensitivity relationships from simulations and real data were well-matched with 99% correlation and 2% root-mean-square (RMS) error. We also discussed the detection characteristics in situations where key assumptions of the model were not met such as fluorescence intensity variation and spatial distribution. Finally, we show that with proper settings, cryo-imaging can provide accurate quantification of the fluorescent cell biodistribution with remarkably high recovery ratios (number of detections/delivery). As cryo-imaging technology has been used in many biological applications, our optimal slice thickness determination and data correction methods can play a crucial role in further advancing its usability and reliability.
Collapse
Affiliation(s)
- Patiwet Wuttisarnwattana
- Biomedical Engineering Institute, Department of Computer Engineering, Excellence Center in Infrastructure Technology and Transportation Engineering, Chiang Mai University, Chiang Mai, 50200, Thailand.
| | - Brendan L Eck
- Imaging Institute, Cleveland Clinic, Cleveland, OH, 44195, USA
- Department of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, 44106, USA
| | | | - David L Wilson
- Department of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, 44106, USA.
| |
Collapse
|
2
|
Wuttisarnwattana P, Auephanwiriyakul S. Spleen Tissue Segmentation Algorithm for Cryo-Imaging Data. J Digit Imaging 2023; 36:588-602. [PMID: 36441277 PMCID: PMC10039202 DOI: 10.1007/s10278-022-00736-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/18/2022] [Revised: 10/30/2022] [Accepted: 10/31/2022] [Indexed: 11/29/2022] Open
Abstract
Spleen tissue segmentation is an essential process for analyzing various immunological diseases as observed in the cryo-imaging data. Because manual labeling of the spleen tissue by human experts is not efficient, an automatic segmentation algorithm is needed. In this study, we developed a novel algorithm for automatically segmenting spleen substructures including white pulp and red pulp for the first time. The algorithm is designed for datasets created by a cryo-imaging system. This unique technology can effectively enable cellular tracking anywhere in the whole mouse with single-cell sensitivity. The proposed algorithm consists of four components: initial spleen mask creation, feature extraction, Supervised Patch-based Fuzzy c-Mean (spFCM) classification, and post-processing. The algorithm accurately and efficiently labeled spleen tissues in all experiment settings. The algorithm also improved the spleen segmentation throughput by 90 folds as compared to the manual segmentation. Moreover, we show that our novel spFCM algorithm outperformed traditional fast-learning classifiers as well as the U-Net deep-learning model in many aspects. Two major contributions of this paper are (1) an explainable algorithm for segmenting spleen tissues in cryo-images for the first time and (2) an spFCM algorithm as a new classifier. We also discussed that our work can be beneficial to researchers who work not only in the fields of graft-versus-host disease (GVHD) mouse models, but also in that of other immunological disease models where spleen analysis is essential. Future work building upon our research may lay the foundations for biomedical studies that utilize cryo-imaging technology.
Collapse
Affiliation(s)
- Patiwet Wuttisarnwattana
- Department of Computer Engineering, Faculty of Engineering, Chiang Mai University, Chiang Mai, 50300, Thailand.
- Optimization Theory and Applications for Engineering Systems Research Group (OASYS), Chiang Mai University, Chiang Mai, 50300, Thailand.
- Excellence Center in Infrastructure Technology and Transportation Engineering (ExCITE), Chiang Mai University, Chiang Mai, 50300, Thailand.
- Biomedical Engineering Institute, Chiang Mai University, Chiang Mai, 50300, Thailand.
| | - Sansanee Auephanwiriyakul
- Department of Computer Engineering, Faculty of Engineering, Chiang Mai University, Chiang Mai, 50300, Thailand.
- Excellence Center in Infrastructure Technology and Transportation Engineering (ExCITE), Chiang Mai University, Chiang Mai, 50300, Thailand.
- Biomedical Engineering Institute, Chiang Mai University, Chiang Mai, 50300, Thailand.
| |
Collapse
|
3
|
Yeh KC, Lee CJ, Song JS, Wu CH, Yeh TK, Wu SH, Hsieh TC, Chen YT, Tseng HY, Huang CL, Chen CT, Jan JJ, Chou MC, Shia KS, Chiang KH. Protective Effect of CXCR4 Antagonist DBPR807 against Ischemia-Reperfusion Injury in a Rat and Porcine Model of Myocardial Infarction: Potential Adjunctive Therapy for Percutaneous Coronary Intervention. Int J Mol Sci 2022; 23:ijms231911730. [PMID: 36233031 PMCID: PMC9570210 DOI: 10.3390/ijms231911730] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/15/2022] [Revised: 09/23/2022] [Accepted: 09/28/2022] [Indexed: 11/25/2022] Open
Abstract
CXCR4 antagonists have been claimed to reduce mortality after myocardial infarction in myocardial infarction (MI) animals, presumably due to suppressing inflammatory responses caused by myocardial ischemia-reperfusion injury, thus, subsequently facilitating tissue repair and cardiac function recovery. This study aims to determine whether a newly designed CXCR4 antagonist DBPR807 could exert better vascular-protective effects than other clinical counterparts (e.g., AMD3100) to alleviate cardiac damage further exacerbated by reperfusion. Consequently, we find that instead of traditional continuous treatment or multiple-dose treatment at different intervals of time, a single-dose treatment of DBPR807 before reperfusion in MI animals could attenuate inflammation via protecting oxidative stress damage and preserve vascular/capillary density and integrity via mobilizing endothelial progenitor cells, leading to a desirable fibrosis reduction and recovery of cardiac function, as evaluated with the LVEF (left ventricular ejection fraction) in infarcted hearts in rats and mini-pigs, respectively. Thus, it is highly suggested that CXCR4 antagonists should be given at a single high dose prior to reperfusion to provide the maximal cardiac functional improvement. Based on its favorable efficacy and safety profiles indicated in tested animals, DBPR807 has a great potential to serve as an adjunctive medicine for percutaneous coronary intervention (PCI) therapies in acute MI patients.
Collapse
Affiliation(s)
- Kai-Chia Yeh
- Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Zhunan 35053, Taiwan
| | - Chia-Jui Lee
- Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Zhunan 35053, Taiwan
| | - Jen-Shin Song
- Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Zhunan 35053, Taiwan
| | - Chien-Huang Wu
- Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Zhunan 35053, Taiwan
| | - Teng-Kuang Yeh
- Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Zhunan 35053, Taiwan
| | - Szu-Huei Wu
- Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Zhunan 35053, Taiwan
| | - Tsung-Chin Hsieh
- Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Zhunan 35053, Taiwan
| | - Yen-Ting Chen
- Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Zhunan 35053, Taiwan
| | - Huan-Yi Tseng
- Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Zhunan 35053, Taiwan
| | - Chen-Lung Huang
- Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Zhunan 35053, Taiwan
| | - Chiung-Tong Chen
- Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Zhunan 35053, Taiwan
| | - Jiing-Jyh Jan
- Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Zhunan 35053, Taiwan
| | - Ming-Chen Chou
- Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Zhunan 35053, Taiwan
| | - Kak-Shan Shia
- Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Zhunan 35053, Taiwan
- Correspondence: (K.-S.S.); (K.-H.C.)
| | - Kuang-Hsing Chiang
- Taipei Heart Institute, Taipei Medical University, Taipei 11031, Taiwan
- Department of Cardiology, Taipei Medical University Hospital, Taipei 11031, Taiwan
- Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan
- Graduate Institute of Biomedical Electronics and Bioinformatics, National Taiwan University, Taipei 106319, Taiwan
- Correspondence: (K.-S.S.); (K.-H.C.)
| |
Collapse
|
4
|
Shin HS, Shin HH, Shudo Y. Current Status and Limitations of Myocardial Infarction Large Animal Models in Cardiovascular Translational Research. Front Bioeng Biotechnol 2021; 9:673683. [PMID: 33996785 PMCID: PMC8116580 DOI: 10.3389/fbioe.2021.673683] [Citation(s) in RCA: 16] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/28/2021] [Accepted: 04/06/2021] [Indexed: 01/16/2023] Open
Abstract
Establishing an appropriate disease model that mimics the complexities of human cardiovascular disease is critical for evaluating the clinical efficacy and translation success. The multifaceted and complex nature of human ischemic heart disease is difficult to recapitulate in animal models. This difficulty is often compounded by the methodological biases introduced in animal studies. Considerable variations across animal species, modifications made in surgical procedures, and inadequate randomization, sample size calculation, blinding, and heterogeneity of animal models used often produce preclinical cardiovascular research that looks promising but is irreproducible and not translatable. Moreover, many published papers are not transparent enough for other investigators to verify the feasibility of the studies and the therapeutics' efficacy. Unfortunately, successful translation of these innovative therapies in such a closed and biased research is difficult. This review discusses some challenges in current preclinical myocardial infarction research, focusing on the following three major inhibitors for its successful translation: Inappropriate disease model, frequent modifications to surgical procedures, and insufficient reporting transparency.
Collapse
Affiliation(s)
- Hye Sook Shin
- Department of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, CA, United States
- Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA, United States
| | - Heather Hyeyoon Shin
- Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, United States
| | - Yasuhiro Shudo
- Department of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, CA, United States
- Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA, United States
| |
Collapse
|
5
|
William W, Ware A, Basaza-Ejiri AH, Obungoloch J. Cervical cancer classification from Pap-smears using an enhanced fuzzy C-means algorithm. INFORMATICS IN MEDICINE UNLOCKED 2019. [DOI: 10.1016/j.imu.2019.02.001] [Citation(s) in RCA: 33] [Impact Index Per Article: 6.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
6
|
Adiponectin improves coronary no-reflow injury by protecting the endothelium in rats with type 2 diabetes mellitus. Biosci Rep 2017; 37:BSR20170282. [PMID: 28667102 PMCID: PMC5529206 DOI: 10.1042/bsr20170282] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/21/2017] [Revised: 06/14/2017] [Accepted: 06/29/2017] [Indexed: 12/25/2022] Open
Abstract
To determine the effect of adiponectin (APN) on the coronary no-reflow (NR) injury in rats with Type 2 diabetes mellitus (T2DM), 80 male Sprague–Dawley rats were fed with a high-sugar–high-fat diet to build a T2DM model. Rats received vehicle or APN in the last week and then were subjected to myocardial ischemia reperfusion (MI/R) injury. Endothelium-dependent vasorelaxation of the thoracic aorta was significantly decreased and serum levels of endothelin-1 (ET-1), intercellular cell adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) were noticably increased in T2DM rats compared with rats without T2DM. Serum APN was positively correlated with the endothelium-dependent vasorelaxation, but negatively correlated with the serum level of ET-1. Treatment with APN improved T2DM-induced endothelium-dependent vasorelaxation, recovered cardiac function, and decreased both NR size and the levels of ET-1, ICAM-1 and VCAM-1. Hypoadiponectinemia was associated with the aggravation of coronary NR in T2DM rats. APN could alleviate coronary NR injury in T2DM rats by protecting the endothelium and improving microcirculation.
Collapse
|
7
|
Hoffman JIE. The history of the microsphere method for measuring blood flows with special reference to myocardial blood flow: a personal memoir. Am J Physiol Heart Circ Physiol 2017; 312:H705-H710. [PMID: 28130341 DOI: 10.1152/ajpheart.00834.2016] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/19/2016] [Revised: 01/09/2017] [Accepted: 01/19/2017] [Indexed: 11/22/2022]
Abstract
We use many types of equipment and technologies to make our measurements but give little thought to how they developed. Evolution was once described as a series of recoils from blind alleys, and this is exemplified by the gradual development of the microsphere method of measuring blood flows. The microsphere method is one of the most frequently used methods for measuring blood flow to organs and portions of organs. The method can measure myocardial blood flow with reasonable accuracy (within 10%) down to samples weighing >50 mg but probably will not do so for samples weighing 1-10 mg. Microspheres with diameters from 10 to 15 μm provide the best compromise between accurate flow measurement and retention in tissue. Radioactive labels have been almst entirely replaced by fluorescent labels, but colored microspheres and neutron-activated labels are also used.NEW & NOTEWORTHY The contributions of the various individuals who developed the microsphere method of measuring regional blood flows and how these advances took place are brought to light in this paper.
Collapse
Affiliation(s)
- Julien I E Hoffman
- Department of Pediatrics, University of California, San Francisco, California
| |
Collapse
|
8
|
Wuttisarnwattana P, Gargesha M, Hof WV, Cooke KR, Wilson DL. Automatic Stem Cell Detection in Microscopic Whole Mouse Cryo-Imaging. IEEE TRANSACTIONS ON MEDICAL IMAGING 2016; 35:819-29. [PMID: 26552080 PMCID: PMC4873963 DOI: 10.1109/tmi.2015.2497285] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/10/2023]
Abstract
With its single cell sensitivity over volumes as large as or larger than a mouse, cryo-imaging enables imaging of stem cell biodistribution, homing, engraftment, and molecular mechanisms. We developed and evaluated a highly automated software tool to detect fluorescently labeled stem cells within very large ( ∼ 200 GB) cryo-imaging datasets. Cell detection steps are: preprocess, remove immaterial regions, spatially filter to create features, identify candidate pixels, classify pixels using bagging decision trees, segment cell patches, and perform 3D labeling. There are options for analysis and visualization. To train the classifier, we created synthetic images by placing realistic digital cell models onto cryo-images of control mice devoid of cells. Very good cell detection results were (precision=98.49%, recall=99.97%) for synthetic cryo-images, (precision=97.81%, recall=97.71%) for manually evaluated, actual cryo-images, and false positives in control mice. An α-multiplier applied to features allows one to correct for experimental variations in cell brightness due to labeling. On dim cells (37% of standard brightness), with correction, we improved recall (49.26%→ 99.36%) without a significant drop in precision (99.99%→ 99.75%) . With tail vein injection, multipotent adult progenitor cells in a graft-versus-host-disease model in the first days post injection were predominantly found in lung, liver, spleen, and bone marrow. Distribution was not simply related to blood flow. The lung contained clusters of cells while other tissues contained single cells. Our methods provided stem cell distribution anywhere in mouse with single cell sensitivity. Methods should provide a rational means of evaluating dosing, delivery methods, cell enhancements, and mechanisms for therapeutic cells.
Collapse
Affiliation(s)
- Patiwet Wuttisarnwattana
- Department of Computer Engineering, Chiang Mai University, Chiang Mai, Thailand, and Biomedical Engineering Center, Chiang Mai University, Chiang Mai, Thailand
| | | | - Wouter van’t Hof
- Cell Processing Facility, Cleveland Cord Blood Center, Cleveland, OH, USA
| | - Kenneth R. Cooke
- Department of Pediatric Oncology, Johns Hopkins University, Baltimore, MD, USA
| | - David L. Wilson
- D.L. Wilson is with Department of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, USA, Department of Radiology, University Hospitals of Cleveland, Cleveland, OH, USA and BioInVision, Inc., Mayfield Village, OH, USA
| |
Collapse
|
9
|
van Deel E, Ridwan Y, van Vliet JN, Belenkov S, Essers J. In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography. J Vis Exp 2016:53603. [PMID: 26967592 PMCID: PMC4828165 DOI: 10.3791/53603] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/19/2023] Open
Abstract
The use of Micro-Computed Tomography (MicroCT) for in vivo studies of small animals as models of human disease has risen tremendously due to the fact that MicroCT provides quantitative high-resolution three-dimensional (3D) anatomical data non-destructively and longitudinally. Most importantly, with the development of a novel preclinical iodinated contrast agent called eXIA160, functional and metabolic assessment of the heart became possible. However, prior to the advent of commercial MicroCT scanners equipped with X-ray flat-panel detector technology and easy-to-use cardio-respiratory gating, preclinical studies of cardiovascular disease (CVD) in small animals required a MicroCT technologist with advanced skills, and thus were impractical for widespread implementation. The goal of this work is to provide a practical guide to the use of the high-speed Quantum FX MicroCT system for comprehensive determination of myocardial global and regional function along with assessment of myocardial perfusion, metabolism and viability in healthy mice and in a cardiac ischemia mouse model induced by permanent occlusion of the left anterior descending coronary artery (LAD).
Collapse
Affiliation(s)
- Elza van Deel
- Department of Genetics, Erasmus MC, Rotterdam; Department of Experimental Cardiology, Erasmus MC, Rotterdam
| | | | | | | | - Jeroen Essers
- Department of Genetics, Erasmus MC, Rotterdam; Department of Vascular Surgery, Erasmus MC, Rotterdam; Department of Radiation Oncology, Erasmus MC, Rotterdam;
| |
Collapse
|
10
|
Uitterdijk A, Springeling T, van Kranenburg M, van Duin RWB, Krabbendam-Peters I, Gorsse-Bakker C, Sneep S, van Haeren R, Verrijk R, van Geuns RJM, van der Giessen WJ, Markkula T, Duncker DJ, van Beusekom HMM. VEGF165Amicrosphere therapy for myocardial infarction suppresses acute cytokine release and increases microvascular density but does not improve cardiac function. Am J Physiol Heart Circ Physiol 2015; 309:H396-406. [DOI: 10.1152/ajpheart.00698.2014] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/29/2014] [Accepted: 05/26/2015] [Indexed: 01/03/2023]
Abstract
Angiogenesis induced by growth factor-releasing microspheres can be an off-the-shelf and immediate alternative to stem cell therapy for acute myocardial infarction (AMI), independent of stem cell yield and comorbidity-induced dysfunction. Reliable and prolonged local delivery of intact proteins such as VEGF is, however, notoriously difficult. Our objective was to create a platform for local angiogenesis in human-sized hearts, using polyethylene-glycol/polybutylene-terephthalate (PEG-PBT) microsphere-based VEGF165Adelivery. PEG-PBT microspheres were biocompatible, distribution was size dependent, and a regimen of 10 × 10615-μm microspheres at 0.5 × 106/min did not induce cardiac necrosis. Efficacy, studied in a porcine model of AMI with reperfusion rather than chronic ischemia used for most reported VEGF studies, shows that microspheres were retained for at least 35 days. Acute VEGF165Arelease attenuated early cytokine release upon reperfusion and produced a dose-dependent increase in microvascular density at 5 wk following AMI. However, it did not improve major variables for global cardiac function, left ventricular dimensions, infarct size, or scar composition (collagen and myocyte content). Taken together, controlled VEGF165Adelivery is safe, attenuates early cytokine release, and leads to a dose-dependent increase in microvascular density in the infarct zone but does not translate into changes in global or regional cardiac function and scar composition.
Collapse
Affiliation(s)
- André Uitterdijk
- Experimental Cardiology, Department of Cardiology, Thoraxcenter, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands
| | - Tirza Springeling
- Department of Cardiology and Radiology, Thoraxcenter, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands
| | - Matthijs van Kranenburg
- Department of Cardiology and Radiology, Thoraxcenter, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands
| | - Richard W. B. van Duin
- Experimental Cardiology, Department of Cardiology, Thoraxcenter, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands
| | - Ilona Krabbendam-Peters
- Experimental Cardiology, Department of Cardiology, Thoraxcenter, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands
| | - Charlotte Gorsse-Bakker
- Experimental Cardiology, Department of Cardiology, Thoraxcenter, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands
| | - Stefan Sneep
- Experimental Cardiology, Department of Cardiology, Thoraxcenter, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands
| | - Rorry van Haeren
- Experimental Cardiology, Department of Cardiology, Thoraxcenter, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands
| | | | - Robert-Jan M. van Geuns
- Department of Cardiology and Radiology, Thoraxcenter, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands
| | - Willem J. van der Giessen
- Experimental Cardiology, Department of Cardiology, Thoraxcenter, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands
| | | | - Dirk J. Duncker
- Experimental Cardiology, Department of Cardiology, Thoraxcenter, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands
| | - Heleen M. M. van Beusekom
- Experimental Cardiology, Department of Cardiology, Thoraxcenter, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands
| |
Collapse
|
11
|
Test-retest repeatability of myocardial blood flow and infarct size using ¹¹C-acetate micro-PET imaging in mice. Eur J Nucl Med Mol Imaging 2015; 42:1589-600. [PMID: 26142729 DOI: 10.1007/s00259-015-3111-9] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/26/2015] [Accepted: 06/04/2015] [Indexed: 12/12/2022]
Abstract
PURPOSE Global and regional responses of absolute myocardial blood flow index (iMBF) are used as surrogate markers to assess response to therapies in coronary artery disease. In this study, we assessed the test-retest repeatability of iMBF imaging, and the accuracy of infarct sizing in mice using (11)C-acetate PET. METHODS (11)C-Acetate cardiac PET images were acquired in healthy controls, endothelial nitric oxide synthase (eNOS) knockout transgenic mice, and mice after myocardial infarction (MI) to estimate global and regional iMBF, and myocardial infarct size compared to (18)F-FDG PET and ex-vivo histology results. RESULTS Global test-retest iMBF values had good coefficients of repeatability (CR) in healthy mice, eNOS knockout mice and normally perfused regions in MI mice (CR = 1.6, 2.0 and 1.5 mL/min/g, respectively). Infarct size measured on (11)C-acetate iMBF images was also repeatable (CR = 17 %) and showed a good correlation with the infarct sizes found on (18)F-FDG PET and histopathology (r (2) > 0.77; p < 0.05). CONCLUSION (11)C-Acetate micro-PET assessment of iMBF and infarct size is repeatable and suitable for serial investigation of coronary artery disease progression and therapy.
Collapse
|
12
|
Sinclair MD, Lee J, Cookson AN, Rivolo S, Hyde ER, Smith NP. Measurement and modeling of coronary blood flow. WILEY INTERDISCIPLINARY REVIEWS-SYSTEMS BIOLOGY AND MEDICINE 2015; 7:335-56. [PMID: 26123867 DOI: 10.1002/wsbm.1309] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/18/2015] [Revised: 05/19/2015] [Accepted: 05/21/2015] [Indexed: 01/10/2023]
Abstract
Ischemic heart disease that comprises both coronary artery disease and microvascular disease is the single greatest cause of death globally. In this context, enhancing our understanding of the interaction of coronary structure and function is not only fundamental for advancing basic physiology but also crucial for identifying new targets for treating these diseases. A central challenge for understanding coronary blood flow is that coronary structure and function exhibit different behaviors across a range of spatial and temporal scales. While experimental studies have sought to understand this feature by isolating specific mechanisms, in tandem, computational modeling is increasingly also providing a unique framework to integrate mechanistic behaviors across different scales. In addition, clinical methods for assessing coronary disease severity are continuously being informed and updated by findings in basic physiology. Coupling these technologies, computational modeling of the coronary circulation is emerging as a bridge between the experimental and clinical domains, providing a framework to integrate imaging and measurements from multiple sources with mathematical descriptions of governing physical laws. State-of-the-art computational modeling is being used to combine mechanistic models with data to provide new insight into coronary physiology, optimization of medical technologies, and new applications to guide clinical practice.
Collapse
Affiliation(s)
- Matthew D Sinclair
- Division of Imaging Sciences and Biomedical Engineering, British Heart Foundation (BHF) Centre of Excellence, King's College London, London, UK
| | - Jack Lee
- Division of Imaging Sciences and Biomedical Engineering, British Heart Foundation (BHF) Centre of Excellence, King's College London, London, UK
| | - Andrew N Cookson
- Division of Imaging Sciences and Biomedical Engineering, British Heart Foundation (BHF) Centre of Excellence, King's College London, London, UK
| | - Simone Rivolo
- Division of Imaging Sciences and Biomedical Engineering, British Heart Foundation (BHF) Centre of Excellence, King's College London, London, UK
| | - Eoin R Hyde
- Division of Imaging Sciences and Biomedical Engineering, British Heart Foundation (BHF) Centre of Excellence, King's College London, London, UK
| | - Nicolas P Smith
- Division of Imaging Sciences and Biomedical Engineering, British Heart Foundation (BHF) Centre of Excellence, King's College London, London, UK.,Department of Engineering, University of Auckland, Auckland, New Zealand
| |
Collapse
|
13
|
Sinclair M, Lee J, Schuster A, Chiribiri A, van den Wijngaard J, van Horssen P, Siebes M, Spaan JAE, Nagel E, Smith NP. Microsphere skimming in the porcine coronary arteries: Implications for flow quantification. Microvasc Res 2015; 100:59-70. [PMID: 25963318 DOI: 10.1016/j.mvr.2015.04.005] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/02/2015] [Revised: 03/28/2015] [Accepted: 04/17/2015] [Indexed: 11/25/2022]
Abstract
Particle skimming is a phenomenon where particles suspended in fluid flowing through vessels distribute disproportionately to bulk fluid volume at junctions. Microspheres are considered a gold standard of intra-organ perfusion measurements and are used widely in studies of flow distribution and quantification. It has previously been hypothesised that skimming at arterial junctions is responsible for a systematic over-estimation of myocardial perfusion from microspheres at the subendocardium. Our objective is to integrate coronary arterial structure and microsphere distribution, imaged at high resolution, to test the hypothesis of microsphere skimming in a porcine left coronary arterial (LCA) network. A detailed network was reconstructed from cryomicrotome imaging data and a Poiseuille flow model was used to simulate flow. A statistical approach using Clopper-Pearson confidence intervals was applied to determine the prevalence of skimming at bifurcations in the LCA. Results reveal that microsphere skimming is most prevalent at bifurcations in the larger coronary arteries, namely the epicardial and transmural arteries. Bifurcations at which skimming was identified have significantly more asymmetric branching parameters. This finding suggests that when using thin transmural segments to quantify flow from microspheres, a skimming-related deposition bias may result in underestimation of perfusion in the subepicardium, and overestimation in the subendocardium.
Collapse
Affiliation(s)
- Matthew Sinclair
- Division of Imaging Sciences and Biomedical Engineering, King's College London, British Heart Foundation (BHF) Centre of Excellence, UK; National Institute of Heath Research (NIHR) Biomedical Research Centre at Guy's and St. Thomas' NHS Foundation Trust, Lambeth Wing, St. Thomas' Hospital, UK; Wellcome Trust and Engineering and Physical Sciences Research Council (EPSRC) Medical Engineering Centre, Lambeth Wing, St. Thomas' Hospital, London, UK
| | - Jack Lee
- Division of Imaging Sciences and Biomedical Engineering, King's College London, British Heart Foundation (BHF) Centre of Excellence, UK; National Institute of Heath Research (NIHR) Biomedical Research Centre at Guy's and St. Thomas' NHS Foundation Trust, Lambeth Wing, St. Thomas' Hospital, UK; Wellcome Trust and Engineering and Physical Sciences Research Council (EPSRC) Medical Engineering Centre, Lambeth Wing, St. Thomas' Hospital, London, UK
| | - Andreas Schuster
- Division of Imaging Sciences and Biomedical Engineering, King's College London, British Heart Foundation (BHF) Centre of Excellence, UK; National Institute of Heath Research (NIHR) Biomedical Research Centre at Guy's and St. Thomas' NHS Foundation Trust, Lambeth Wing, St. Thomas' Hospital, UK; Wellcome Trust and Engineering and Physical Sciences Research Council (EPSRC) Medical Engineering Centre, Lambeth Wing, St. Thomas' Hospital, London, UK; Department of Cardiology and Pneumology, Georg-August-University, Göttingen, Germany; German Centre for Cardiovascular Research (DZHK, Partner Site Göttingen), Göttingen, Germany
| | - Amedeo Chiribiri
- Division of Imaging Sciences and Biomedical Engineering, King's College London, British Heart Foundation (BHF) Centre of Excellence, UK; National Institute of Heath Research (NIHR) Biomedical Research Centre at Guy's and St. Thomas' NHS Foundation Trust, Lambeth Wing, St. Thomas' Hospital, UK; Wellcome Trust and Engineering and Physical Sciences Research Council (EPSRC) Medical Engineering Centre, Lambeth Wing, St. Thomas' Hospital, London, UK
| | - Jeroen van den Wijngaard
- Department of Biomedical Engineering & Physics, Academic Medical Centre, Amsterdam, The Netherlands
| | - Pepijn van Horssen
- Department of Biomedical Engineering & Physics, Academic Medical Centre, Amsterdam, The Netherlands
| | - Maria Siebes
- Department of Biomedical Engineering & Physics, Academic Medical Centre, Amsterdam, The Netherlands
| | - Jos A E Spaan
- Department of Biomedical Engineering & Physics, Academic Medical Centre, Amsterdam, The Netherlands
| | - Eike Nagel
- Division of Imaging Sciences and Biomedical Engineering, King's College London, British Heart Foundation (BHF) Centre of Excellence, UK; National Institute of Heath Research (NIHR) Biomedical Research Centre at Guy's and St. Thomas' NHS Foundation Trust, Lambeth Wing, St. Thomas' Hospital, UK; Wellcome Trust and Engineering and Physical Sciences Research Council (EPSRC) Medical Engineering Centre, Lambeth Wing, St. Thomas' Hospital, London, UK
| | - Nicolas P Smith
- Division of Imaging Sciences and Biomedical Engineering, King's College London, British Heart Foundation (BHF) Centre of Excellence, UK; National Institute of Heath Research (NIHR) Biomedical Research Centre at Guy's and St. Thomas' NHS Foundation Trust, Lambeth Wing, St. Thomas' Hospital, UK; Wellcome Trust and Engineering and Physical Sciences Research Council (EPSRC) Medical Engineering Centre, Lambeth Wing, St. Thomas' Hospital, London, UK; Department of Engineering, University of Auckland, Auckland, New Zealand.
| |
Collapse
|
14
|
|